FIELD: medicine.
SUBSTANCE: patients with stage IIB-IIIA lung cancer without concomitant diabetes additionally receive metformin after completion of radical combined or complex treatment. Administration is carried out orally at a dose of 250 mg per day for 2 years.
EFFECT: decreased frequency of recurrence and generalization of the tumour process.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF COMBINATION TREATMENT OF STAGE IIIA-IIIB LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER | 2010 |
|
RU2431450C1 |
| METHOD FOR PREDICTION OF RISK OF RECURRENT DISEASE OF SQUAMOUS CELL LUNG CANCER OF STAGE IIB-IIIA IN PATIENTS RECEIVING ADJUVANT POLYCHEMOTHERAPY AFTER RADICAL SURGERY | 2023 |
|
RU2815575C1 |
| METHOD OF COMBINED TREATMENT OF PATIENTS WITH CENTRAL LUNG CANCER AFTER PERFORMING CONDITIONALLY RADICAL SURGICAL INTERVENTIONS | 2023 |
|
RU2807897C1 |
| METHOD OF TREATMENT OF PATIENTS WITH LOCAL NON-SMALL CELL LUNG CANCER | 2007 |
|
RU2361580C2 |
| METHOD OF COMBINATION TREATMENT OF NON-SMALL CELL LUNG CANCER STAGE 1B-111 WITH CUSTOMIZATION OF ADJUVANT CHEMOTHERAPY | 2015 |
|
RU2593342C1 |
| METHOD OF PREOPERATIVE PREPARATION OF LUNG CANCER PATIENTS WITH CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2023 |
|
RU2796736C1 |
| METHOD FOR TREATING LUNG CANCER | 2015 |
|
RU2578963C1 |
| METHOD OF TREATING OVARIAN CANCER, VERSIONS OF ITS METASTASIS AND RECURRENCE | 2015 |
|
RU2582939C1 |
| METHOD OF COMBINATION TREATMENT OF LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER | 2010 |
|
RU2444384C1 |
| METHOD FOR OPTIMIZING PERIOPERATIVE PERIOD OF ELDERLY AND SENILE PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN SURGICAL TREATMENT OF LUNG CANCER | 2020 |
|
RU2757580C1 |
